Finally, our results show that tumor tissues in GBM patients highly express IRF3 and IRF7, encoding interferon regulatory factors that can lead to the transcription of caspase-11, which is important for noncanonical NLRP3 inflammasome activation, via activation of the JAK/STAT pathway48–50. The gene discussed is SOAT1; the disease is glioblastoma.